Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Lidocaine HCL (PF) Injection, LIDOCAINE HCL 4% (PF) 40 MG/ML INJECTABLE, For ocular injection, Preservative free, disca
Recalled March 11, 2020 · FDA recall D-0962-2020 · Fusion IV Pharmaceuticals, Inc.
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
N/A
Sold at
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Description
Lack of Assurance of Sterility
Product
Lidocaine HCL (PF) Injection, LIDOCAINE HCL 4% (PF) 40 MG/ML INJECTABLE, For ocular injection, Preservative free, discard unused portion, protect from light, 5 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-1011-5
Manufacturer(s)
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →